OCUCLEAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ocuclear, and what generic alternatives are available?
Ocuclear is a drug marketed by Bayer Healthcare Llc and is included in one NDA.
The generic ingredient in OCUCLEAR is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OCUCLEAR?
- What are the global sales for OCUCLEAR?
- What is Average Wholesale Price for OCUCLEAR?
Summary for OCUCLEAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 1,937 |
| DailyMed Link: | OCUCLEAR at DailyMed |
US Patents and Regulatory Information for OCUCLEAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare Llc | OCUCLEAR | oxymetazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 018471-001 | May 30, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
